364 related articles for article (PubMed ID: 9301522)
1. Differential functional effects of a humanized anti-CD4 antibody on resting and activated human T cells.
Brett SJ; Rowan W; Smith M; Bartholomew M; Tite JP
Immunology; 1997 Jul; 91(3):346-53. PubMed ID: 9301522
[TBL] [Abstract][Full Text] [Related]
2. Non-Fc receptor-binding humanized anti-CD3 antibodies induce apoptosis of activated human T cells.
Carpenter PA; Pavlovic S; Tso JY; Press OW; Gooley T; Yu XZ; Anasetti C
J Immunol; 2000 Dec; 165(11):6205-13. PubMed ID: 11086054
[TBL] [Abstract][Full Text] [Related]
3. Functional analysis of the effects of a fully humanized anti-CD4 antibody on resting and activated human T cells.
Bartholomew M; Brett S; Barber K; Rossman C; Crowe S; Tite J
Immunology; 1995 May; 85(1):41-8. PubMed ID: 7635520
[TBL] [Abstract][Full Text] [Related]
4. Anti-CD3-based bispecific antibody designed for therapy of human B-cell malignancy can induce T-cell activation by antigen-dependent and antigen-independent mechanisms.
Link BK; Kostelny SA; Cole MS; Fusselman WP; Tso JY; Weiner GJ
Int J Cancer; 1998 Jul; 77(2):251-6. PubMed ID: 9650561
[TBL] [Abstract][Full Text] [Related]
5. Human CD4 modulation in vivo induced by antibody treatment.
Horneff G; Guse AH; Schulze-Koops H; Kalden JR; Burmester GR; Emmrich F
Clin Immunol Immunopathol; 1993 Jan; 66(1):80-90. PubMed ID: 8440076
[TBL] [Abstract][Full Text] [Related]
6. Human T cell activation induced by a monoclonal mouse IgG3 anti-CD3 antibody (RIV9) requires binding of the Fc part of the antibody to the monocytic 72-kDa high-affinity Fc receptor (FcRI).
Ceuppens JL; Van Vaeck F
Cell Immunol; 1989 Jan; 118(1):136-46. PubMed ID: 2521302
[TBL] [Abstract][Full Text] [Related]
7. A small number of anti-CD3 molecules on dendritic cells stimulate DNA synthesis in mouse T lymphocytes.
Romani N; Inaba K; Puré E; Crowley M; Witmer-Pack M; Steinman RM
J Exp Med; 1989 Mar; 169(3):1153-68. PubMed ID: 2522496
[TBL] [Abstract][Full Text] [Related]
8. Cross-linking of the CAMPATH-1 antigen (CD52) triggers activation of normal human T lymphocytes.
Rowan WC; Hale G; Tite JP; Brett SJ
Int Immunol; 1995 Jan; 7(1):69-77. PubMed ID: 7718516
[TBL] [Abstract][Full Text] [Related]
9. Preincubation with anti-CD4 influences activation of human T cells by subsequent co-cross-linking of CD4 with CD3.
Tsygankov AY; Bröker BM; Guse AH; Meinke U; Roth E; Rossmann C; Emmrich F
J Leukoc Biol; 1993 Nov; 54(5):430-8. PubMed ID: 8228621
[TBL] [Abstract][Full Text] [Related]
10. Induction of T cell proliferation with anti-CD3 switch-variant monoclonal antibodies: effects of heavy chain isotype in monocyte-dependent systems.
Van Lier RA; Boot JH; De Groot ER; Aarden LA
Eur J Immunol; 1987 Nov; 17(11):1599-604. PubMed ID: 2960543
[TBL] [Abstract][Full Text] [Related]
11. CD4 dependence of activation threshold and TCR signalling in mouse T lymphocytes.
Feito MJ; Ballester S; Díez-Orejas R; Ojeda G; Criado G; Portolés P; Rojo JM
Scand J Immunol; 1997 Feb; 45(2):166-74. PubMed ID: 9042429
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of cell surface CD4 molecule expression induced by anti-CD4 antibodies in human T lymphocytes.
Morel P; Vincent C; Wijdenes J; Revillard JP
Cell Immunol; 1992 Dec; 145(2):287-98. PubMed ID: 1451179
[TBL] [Abstract][Full Text] [Related]
13. Valency of CD3 binding and internalization of the CD3 cell-surface complex control T cell responses to second signals: distinction between effects on protein kinase C, cytoplasmic free calcium, and proliferation.
Ledbetter JA; June CH; Martin PJ; Spooner CE; Hansen JA; Meier KE
J Immunol; 1986 Jun; 136(11):3945-52. PubMed ID: 3084650
[TBL] [Abstract][Full Text] [Related]
14. HuM291(Nuvion), a humanized Fc receptor-nonbinding antibody against CD3, anergizes peripheral blood T cells as partial agonist of the T cell receptor.
Chau LA; Tso JY; Melrose J; Madrenas J
Transplantation; 2001 Apr; 71(7):941-50. PubMed ID: 11349730
[TBL] [Abstract][Full Text] [Related]
15. Anti-CD4 antibody treatment of patients with rheumatoid arthritis: II. Effect of in vivo treatment on in vitro proliferative response of CD4 cells.
Walker C; Herzog C; Rieber P; Riethmüller G; Müller W; Pichler WJ
J Autoimmun; 1989 Oct; 2(5):643-9. PubMed ID: 2572231
[TBL] [Abstract][Full Text] [Related]
16. OKT3 F(ab')2 fragments--retention of the immunosuppressive properties of whole antibody with marked reduction in T cell activation and lymphokine release.
Woodle ES; Thistlethwaite JR; Ghobrial IA; Jolliffe LK; Stuart FP; Bluestone JA
Transplantation; 1991 Aug; 52(2):354-60. PubMed ID: 1908148
[TBL] [Abstract][Full Text] [Related]
17. Bispecific antibody-directed antitumor activity of human CD4+ helper/killer T cells induced by anti-CD3 monoclonal antibody plus interleukin 2.
Nishimura T; Nakamura Y; Takeuchi Y; Gao XH; Tokuda Y; Okumura K; Habu S
Jpn J Cancer Res; 1991 Nov; 82(11):1207-10. PubMed ID: 1836455
[TBL] [Abstract][Full Text] [Related]
18. The anti-CD2 monoclonal antibody BTI-322 generates unresponsiveness by activation-associated T cell depletion.
Xu Y; Kolber-Simonds D; Hope JA; Bazin H; Latinne D; Monroy R; White-Scharf ME; Schuurman HJ
Clin Exp Immunol; 2004 Dec; 138(3):476-83. PubMed ID: 15544625
[TBL] [Abstract][Full Text] [Related]
19. Patterns of costimulation of T cell clones by cross-linking CD3, CD4/CD8, and class I MHC molecules.
Wacholtz MC; Patel SS; Lipsky PE
J Immunol; 1989 Jun; 142(12):4201-12. PubMed ID: 2470819
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of CD4 and CD8 engagement on the development of cytokine profiles of murine CD4+ and CD8+ T lymphocytes.
Campbell SB; Komata T; Kelso A
Immunology; 2000 Mar; 99(3):394-401. PubMed ID: 10712669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
